Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $2.330.00 (0.00%)
ExchangeNASDAQ GS
Volume0
Today's Open$0.00
Previous Close$2.33
Data as of 08/17/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $2.33 with a 52 week high of $5.26 and a 52 week low of $2.22.
Recent News

August 09, 2018

NantHealth Reports 2018 Second-Quarter Financial Results

Liquid GPS® Successfully Launched in Q2 Total Revenue in Q2 was $22.0 Million Revenue in 2017 Q2 included a large completed Connected Care device implementation of approximately $4 million, benefiting prior period revenue of $23.5 million SaaS revenue of $16.2 million in Q2, up 9% from $14.9 million in prior year Q2 In June...

Read More >

August 03, 2018

NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9

CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will ...

Read More >

June 20, 2018

NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange and Authorization Appeals

Further Enhancing NaviNet Open’s Ability to Tackle Payer-Provider Communication Challenges LOS ANGELES--(BUSINESS WIRE)--Jun. 20, 2018-- NantHealth, Inc. (NASDAQ: NH) announced two exciting new product launches - Provider Initiated Document Exchange and Authorization Appeals - on the nation’s leading payer-provider collaboration platform, NaviNet® Open, at the 2018 AHIP Institute and Expo. Today, the exchange of information betw...

Read More >

Upcoming Events
There are currently no events scheduled.